Urine Analysis - Medical Devices Pipeline Assessment, 2017

  • ID: 4318298
  • Report
  • 61 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Erba Diagnostics, Inc.
  • Imperial College London
  • IRIS International Inc
  • LifeAssays AB
  • MORE
Urine Analysis - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Urine Analysis - Medical Devices Pipeline Assessment, 2017" provides an overview of Urine Analysis currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analysis pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Urine Analysis under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Urine Analysis and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Urine Analysis under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Erba Diagnostics, Inc.
  • Imperial College London
  • IRIS International Inc
  • LifeAssays AB
  • MORE
1 Table of Contents
2 Introduction
2.1 Urine Analysis Overview
3 Products under Development
3.1 Urine Analysis - Pipeline Products by Stage of Development
3.2 Urine Analysis - Pipeline Products by Segment
3.3 Urine Analysis - Pipeline Products by Territory
3.4 Urine Analysis - Pipeline Products by Regulatory Path
3.5 Urine Analysis - Pipeline Products by Estimated Approval Date
3.6 Urine Analysis - Ongoing Clinical Trials
4 Urine Analysis - Pipeline Products under Development by Companies
4.1 Urine Analysis Companies - Pipeline Products by Stage of Development
4.2 Urine Analysis - Pipeline Products by Stage of Development
5 Urine Analysis Companies and Product Overview
5.1 Analyticon Biotechnologies AG Company Overview
5.1.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
5.2 Biosense Technologies Pvt Ltd. Company Overview
5.2.1 Biosense Technologies Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.3 California Pacific Medical Center Research Institute Company Overview
5.3.1 California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview
5.4 Erba Diagnostics, Inc. Company Overview
5.4.1 Erba Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Imperial College London Company Overview
5.5.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
5.6 IRIS International Inc Company Overview
5.6.1 IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 LifeAssays AB Company Overview
5.7.1 LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview
5.8 Roche Diagnostics International Ltd Company Overview
5.8.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Scanadu HQ Company Overview
5.9.1 Scanadu HQ Pipeline Products & Ongoing Clinical Trials Overview
5.10 Sebia SA Company Overview
5.10.1 Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
5.11 Siemens Healthcare GmbH Company Overview
5.11.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.12 Stanford University Company Overview
5.12.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview
5.13 Sysmex Corp Company Overview
5.13.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
5.14 Teco Diagnostics Company Overview
5.14.1 Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.15 Trinity College Dublin Company Overview
5.15.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
5.16 University of Kentucky Company Overview
5.16.1 University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview
6 Urine Analysis- Recent Developments
6.1 May 21, 2017: Sysmex New Zealand Commence Direct Sales of Urinalysis Instrument Portfolio
6.2 May 10, 2017: Streck signs distribution agreement with Genomax Technologies
6.3 May 04, 2017: Bio-Rad Reports First-Quarter 2017 Financial Results
6.4 May 02, 2017: Sphere Medical Holding: Commercialisation Update
6.5 Apr 10, 2017: Streck signs distribution agreement with RUWAG Diagnostics
6.6 Apr 03, 2017: Sysmex Establishes New Company, Sysmex Harmony, to Promote the Employment of People with Disabilities
6.7 Mar 31, 2017: HORIBA Instruments commences operations at new factory in Houston
6.8 Mar 29, 2017: Sysmex America Announces Leadership Promotions
6.9 Mar 20, 2017: EKF Diagnostics Holdings: Final results
6.10 Mar 13, 2017: Bio-Rad Intends to Propose Three New Independent Directors
6.11 Mar 13, 2017: Bio-Rad Initiates Long Term Financial Guidance; Commits to Defining Long Term Capital Allocation Targets and Hosting an Annual Investor Day
6.12 Feb 23, 2017: VBio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.13 Feb 23, 2017: Bio-Rad Reports Fourth-Quarter and Full-Year 2016 Financial Results
6.14 Feb 22, 2017: U.S. ARKRAY announces the launch of the AUTION ELEVEN AE-4022 Semi-Automated Urine Analyzer
6.15 Feb 01, 2017: Streck signs distribution agreement with HiSS Diagnostics
6.16 Dec 15, 2016: Next generation Proxima launched
6.17 Nov 29, 2016: ERBA Diagnostics names interim CEO
6.18 Nov 01, 2016: Bio-Rad Reports Third-Quarter Currency-Neutral Revenue Growth of 9.1 Percent
6.19 Oct 17, 2016: New design of hematology and clinical chemistry analyzers
6.20 Oct 13, 2016: Eric Riley joins Streck as Human Resources Director
6.21 Sep 30, 2016: Proxima 4 CE mark achieved
6.22 Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report
6.23 Aug 03, 2016: Bio-Rad Reports Second-Quarter 2016 Financial Results
6.24 Jul 21, 2016: Sphere Medical Holding: Appointment of Regional Distributor and Company Update
6.25 Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Urine Analysis - Pipeline Products by Stage of Development
Table 2: Urine Analysis - Pipeline Products by Segment
Table 3: Urine Analysis - Pipeline Products by Territory
Table 4: Urine Analysis - Pipeline Products by Regulatory Path
Table 5: Urine Analysis - Pipeline Products by Estimated Approval Date
Table 6: Urine Analysis - Ongoing Clinical Trials
Table 7: Urine Analysis Companies - Pipeline Products by Stage of Development
Table 8: Urine Analysis - Pipeline Products by Stage of Development
Table 9: Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview
Table 10: CombiScan XL - Product Status
Table 11: CombiScan XL - Product Description
Table 12: Biosense Technologies Pvt Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 13: uChek Universal - Product Status
Table 14: uChek Universal - Product Description
Table 15: California Pacific Medical Center Research Institute Pipeline Products & Ongoing Clinical Trials Overview
Table 16: Urinary Proteome Monitoring Assay - Product Status
Table 17: Urinary Proteome Monitoring Assay - Product Description
Table 18: Erba Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 19: Laura XL - Product Status
Table 20: Laura XL - Product Description
Table 21: Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Diagnostic Test - Autism - Product Status
Table 23: Diagnostic Test - Autism - Product Description
Table 24: IRIS International Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: 3GEMS Next Generation Urinalysis Platform - Product Status
Table 26: 3GEMS Next Generation Urinalysis Platform - Product Description
Table 27: LifeAssays AB Pipeline Products & Ongoing Clinical Trials Overview
Table 28: LifeAssays U-Albumin - Product Status
Table 29: LifeAssays U-Albumin - Product Description
Table 30: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Cobas 6500 Analyzer - Product Status
Table 32: Cobas 6500 Analyzer - Product Description
Table 33: Scanadu HQ Pipeline Products & Ongoing Clinical Trials Overview
Table 34: Scanadu Urine - Product Status
Table 35: Scanadu Urine - Product Description
Table 36: Scanadu HQ - Ongoing Clinical Trials Overview
Table 37: Scanadu Urine - Scanadu Urine Device Validation Study Protocol
Table 38: Sebia SA Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Capillarys 3 Tera Assay - Urine - Product Status
Table 40: Capillarys 3 Tera Assay - Urine - Product Description
Table 41: Capillarys 3 Tera Assay - Urine IT - Product Status
Table 42: Capillarys 3 Tera Assay - Urine IT - Product Description
Table 43: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Clinitek Atlas Next - Product Status
Table 45: Clinitek Atlas Next - Product Description
Table 46: Stanford University Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Biostrip Test - Urine Analysis - Product Status
Table 48: Biostrip Test - Urine Analysis - Product Description
Table 49: Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Status
Table 51: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Description
Table 52: UC-3500 - Product Status
Table 53: UC-3500 - Product Description
Table 54: UF-5000 - Product Status
Table 55: UF-5000 - Product Description
Table 56: Teco Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Next Generation Urine Analyzer - Product Status
Table 58: Next Generation Urine Analyzer - Product Description
Table 59: Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview
Table 60: epiCaPture - Product Status
Table 61: epiCaPture - Product Description
Table 62: University of Kentucky Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Status
Table 64: Diagnostic Gene-Expression Test - Interstitial Cystitis - Product Description
Table 65: Glossary

List of Figures
Figure 1: Urine Analysis - Pipeline Products by Stage of Development
Figure 2: Urine Analysis - Pipeline Products by Segment
Figure 3: Urine Analysis - Pipeline Products by Territory
Figure 4: Urine Analysis - Pipeline Products by Regulatory Path
Figure 5: Urine Analysis - Pipeline Products by Estimated Approval Date
Figure 6: Urine Analysis - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Analyticon Biotechnologies AG
  • Biosense Technologies Pvt Ltd.
  • California Pacific Medical Center Research Institute
  • Erba Diagnostics, Inc.
  • Imperial College London
  • IRIS International Inc
  • LifeAssays AB
  • Roche Diagnostics International L
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll